The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Tetsche, Mette S ^a,b   Dethlefsen, Claus ^b   Pedersen, Lars ^a   Sorensen, Henrik T ^a,c   Norgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; SCORING SYSTEM; SURVIVAL TIME; CANCER INVASION; CAUSE OF DEATH; INCIDENCE; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; SEX RATIO; SURVIVAL;

AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 40749109360     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-31     Document Type: Article

References (38)

1. Sant M Aareleid T Berrino F Bielska LM Carli PM Faivre J Grosclaude P Hedelin G Matsuda T Moller H Moller T Verdecchia A Capocaccia R Gatta G Micheli A Santaquilani M Roazzi P Lisi D EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - results and commentary Ann Oncol 2003, 14 Suppl 5:v61-118. 10.1093/annonc/mdg754 14684501
2. Janssen-Heijnen ML Houterman S Lemmens VE Louwman MW Coebergh JW Age and co-morbidity in cancer patients: A population-based approach Cancer Treat Res 2005, 124:89-107. 15839192
3. Sharma S Driscoll D Odunsi K Venkatadri A Lele S Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients Am J Obstet Gynecol 2005, 193:2077-2082. 10.1016/j.ajog.2005.06.074 16325619
4. de Groot V Beckerman H Lankhorst GJ Bouter LM How to measure comorbidity. a critical review of available methods J Clin Epidemiol 2003, 56:221-229. 10.1016/S0895-4356(02)00585-1 12725876
5. West DW Satariano WA Ragland DR Hiatt RA Comorbidity and breast cancer survival: A comparison between black and white women Ann Epidemiol 1996, 6:413-419. 10.1016/S1047-2797(96)00096-8 8915472
6. Maas HA Kruitwagen RF Lemmens VE Goey SH Janssen-Heijnen ML The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: A population-based study Gynecol Oncol 2005, 97:104-109. 10.1016/ j.ygyno.2004.12.026 15790445
7. du Bois A Rochon J Lamparter C Pfisterer J Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer Int J Gynecol Cancer 2005, 15:183-191. 10.1111/j.1525-1438.2005.15202.x 15823098
8. DiSilvestro P Peipert JF Hogan JW Granai CO Prognostic value of clinical variables in ovarian cancer J Clin Epidemiol 1997, 50:501-505. 10.1016/ S0895-4356(97)00002-4 9180642
9. O'Malley CD Cress RD Campleman SL Leiserowitz GS Survival of Californian women with epithelial ovarian cancer, 1994-1996: A population-based study Gynecol Oncol 2003, 91:608-615. 10.1016/j.ygyno.2003.08.010 14675685
10. Janssen-Heijnen ML Houterman S Lemmens VE Louwman MW Maas HA Coebergh JW Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach Crit Rev Oncol Hematol 2005, 55:231-240. 10.1016/j.critrevonc.2005.04.008 15979890
11. Tingulstad S Skjeldestad FE Halvorsen TB Hagen B Survival and prognostic factors in patients with ovarian cancer Obstet Gynecol 2003, 101:885-891. 10.1016/S0029-7844(03)00123-6 12738145
12. Tetsche MS Norgaard M Jacobsen J Wogelius P Sorensen HT Comorbidity and ovarian cancer survival in Denmark, 1995-2005: A population-based cohort study Int J Gynecol Cancer 2007. 17692093
13. Marx CI Moller C Bendixen A Kehlet H Ottesen BS [Ovarian cancer in Denmark. Status of the surgical intervention] Ugeskr Laeger 2006, 168:1537-1540. 16640975
14. Storm HH Michelsen EV Clemmensen IH Pihl J The Danish Cancer Registry - history, content, quality and use Dan Med Bull 1997, 44:535-539. 9408738
15. oncology FIGO Staging classifications and clinical practice guidelines of gynaecologic cancers 2000 http://www.figo.org/docs/staging_booklet.pdf
16. Kjaerbye-Thygesen A Huusom LD Frederiksen K Kjaer SK Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries Acta Obstet Gynecol Scand 2005, 84:1006-1012. 10.1111/j.0001-6349.2005.00878.x 16167920
17. The Danish Cancer Registry 2006 http://www.sundhed.registre/ car.xls
18. National Broad of Health HS Cancer Incidence in Denmark 1999 Copenhagen 2003
19. Andersen TF Madsen M Jorgensen J Mellemkjoer L Olsen JH The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 1999, 46:263-268. 10421985
20. Sundhedsstyrelsen The National Board of Health 2007 http://www.sundheds.ister.aspx?lang=da
21. Charlson ME Pompei P Ales KL MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8 3558716
22. Nuttall M van der MJ Emberton M Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery J Clin Epidemiol 2006, 59:265-273. 10.1016/j.jclinepi.2005.07.015 16488357
23. Rieker RJ Hammer E Eisele R Schmid E Hogel J The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection Langenbecks Arch Surg 2002, 387:72-76. 10.1007/s00423-002-0291-0 12111258
24. Birim O Kappetein AP Bogers AJ Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Eur J Cardiothorac Surg 2005, 28:759-762. 10.1016/j.ejcts.2005.06.046 16157485
25. Newschaffer CJ Bush TL Penberthy LT Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data J Clin Epidemiol 1997, 50:725-733. 10.1016/S0895-4356(97)00050-4 9250271
26. Frank L Epidemiology. When an entire country is a cohort Science 2000, 287:2398-2399. 10.1126/science.287.5462.2398 10766613
27. Kirkwood BR Sterne JA Medical Statistics Oxford, Blackwell Publishing F. G and V. P 2nd ed 2003
28. DR. C Regression Models and Life-Tables Journal of the Royal Statistical Society, Series B 1972, 34:187-220.
29. Rothman KJ Epidemiology An Introduction Oxford, Oxford University Press 2nd 2002
30. Tetsche MS Nørgaard M Skriver MV Andersen ES Lash TL Sørensen HT Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol 2005, 26:266-270. 15991523
31. Sørensen HT Regional administrative health registries as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with example of use. Int J Risk Safety Med 1997, 10:1-22.
32. Wilchesky M Tamblyn RM Huang A Validation of diagnostic codes within medical services claims J Clin Epidemiol 2004, 57:131-141. 10.1016/ S0895-4356(03)00246-4 15125622
33. Yemelyanova AV Cosin JA Bidus MA Boice CR Seidman JD Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening Int J Gynecol Cancer 2007. 17868343
34. Read WL Tierney RM Page NC Costas I Govindan R Spitznagel EL Piccirillo JF Differential prognostic impact of comorbidity J Clin Oncol 2004, 22:3099-3103. 10.1200/JCO.2004.08.040 15284260
35. Nagel G Wedding U Hoyer H Rohrig B Katenkamp D The impact of comorbidity on the survival of postmenopausal women with breast cancer J Cancer Res Clin Oncol 2004. 15300426
36. Vasey PA Herrstedt J Jelic S ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of epithelial ovarian carcinoma Ann Oncol 2005, 16 Suppl 1:i13-i15. 10.1093/annonc/mdi823 15888736
37. Gijsen R Hoeymans N Schellevis FG Ruwaard D Satariano WA van den Bos GA Causes and consequences of comorbidity: A review J Clin Epidemiol 2001, 54:661-674. 10.1016/S0895-4356(00)00363-2 11438406
38. Monfardini S Prescribing anti-cancer drugs in elderly cancer patients Eur J Cancer 2002, 38:2341-2346. 10.1016/S0959-8049(02)00266-6 12460777